mutLBSgeneDB |
Gene summary for DAPK1 |
Gene summary |
Basic gene Info. | Gene symbol | DAPK1 |
Gene name | death-associated protein kinase 1 | |
Synonyms | DAPK | |
Cytomap | UCSC genome browser: 9q21.33 | |
Type of gene | protein-coding | |
RefGenes | NM_001288729.1, NM_001288730.1,NM_001288731.1,NM_004938.3, | |
Description | DAP kinase 1 | |
Modification date | 20141207 | |
dbXrefs | MIM : 600831 | |
HGNC : HGNC | ||
Ensembl : ENSG00000196730 | ||
HPRD : 02902 | ||
Vega : OTTHUMG00000020150 | ||
Protein | UniProt: P53355 go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_DAPK1 | |
BioGPS: 1612 | ||
Pathway | NCI Pathway Interaction Database: DAPK1 | |
KEGG: DAPK1 | ||
REACTOME: DAPK1 | ||
Pathway Commons: DAPK1 | ||
Context | iHOP: DAPK1 | |
ligand binding site mutation search in PubMed: DAPK1 | ||
UCL Cancer Institute: DAPK1 | ||
Assigned class in mutLBSgeneDB | B: This gene belongs to targetable_mutLBSgenes. |
Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
GO ID | GO Term | PubMed ID | GO:0006468 | protein phosphorylation | 10629061 | GO:0017148 | negative regulation of translation | 18995835 | GO:0035556 | intracellular signal transduction | 10629061 | GO:0043280 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic process | 16132846 | GO:0046777 | protein autophosphorylation | 10629061 | GO:0071346 | cellular response to interferon-gamma | 18995835 |
Top |
Ligand binding site mutations for DAPK1 |
Lollipop-style diagram of mutations at LBS in amino-acid sequence. We represented ligand binding site mutations only. (You can see big image via clicking.) : non-synonymous mutation on LBS, Circle size denotes number of samples. |
Cancer type specific mutLBS sorted by frequency |
LBS | AAchange of nsSNV | Cancer type | # samples | K29 | R31H | COAD | 1 | F183 | A185T | COAD | 1 | V96 | V96I | COAD | 1 | P181 | T180I | SKCM | 1 | K42,A40 | A41S | STAD | 1 | G16 | G16R | UCEC | 1 | F183 | F183C | UCEC | 1 | K29 | R31H | UCEC | 1 |
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma. |
Top |
Protein structure related information for DAPK1 |
Relative protein structure stability change (ΔΔE) using Mupro 1.1 Mupro score denotes assessment of the effect of mutations on thermodynamic stability. (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability) |
: nsSNV at non-LBS: nsSNV at LBS |
nsSNVs sorted by the relative stability change of protein structure by each mutation Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene. |
LBS | AAchange of nsSNV | Relative stability change | A40 | A41S | -1.683053 | K42 | A41S | -1.683053 | F183 | F183C | -1.5054834 | K29 | R31H | -1.2585989 | V96 | V96I | -0.90753522 | F183 | A185T | -0.81484589 | P181 | T180I | -0.45656135 | G16 | G16R | -0.013812536 |
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132) |
Structure image for DAPK1 from PDB |
Top |
Differential gene expression and gene-gene network for DAPK1 |
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types |
Differential co-expressed gene network based on protein-protein interaction data (CePIN) |
Top |
Top |
Phenotype information for DAPK1 |
Gene level disease information (DisGeNet) |
Disease ID | Disease name | # PubMed | Association type |
umls:C0007131 | Carcinoma, Non-Small-Cell Lung | 8 | Biomarker |
umls:C0023467 | Leukemia, Myeloid, Acute | 7 | AlteredExpression, Biomarker |
umls:C0001418 | Adenocarcinoma | 6 | Biomarker |
umls:C0026986 | Myelodysplastic Syndromes | 6 | Biomarker |
umls:C0007134 | Carcinoma, Renal Cell | 5 | Biomarker |
umls:C0007138 | Carcinoma, Transitional Cell | 5 | Biomarker |
umls:C0024121 | Lung Neoplasms | 4 | Biomarker |
umls:C0027627 | Neoplasm Metastasis | 4 | Biomarker |
umls:C0010606 | Carcinoma, Adenoid Cystic | 2 | Biomarker |
umls:C0036095 | Salivary Gland Neoplasms | 2 | Biomarker |
umls:C0006118 | Brain Neoplasms | 1 | Biomarker |
umls:C0009759 | Conjunctival Diseases | 1 | Biomarker |
umls:C0085183 | Neoplasms, Second Primary | 1 | Biomarker |
umls:C0031117 | Peripheral Nervous System Diseases | 1 | Biomarker |
umls:C0035242 | Respiratory Tract Diseases | 1 | Biomarker |
Mutation level pathogenic information (ClinVar annotation) |
Allele ID | AA change | Clinical significance | Origin | Phenotype IDs |
Top |
Pharmacological information for DAPK1 |
Gene expression profile of anticancer drug treated cell-lines (CCLE) Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient. |
Gene-centered drug-gene interaction network |
Drug information targeting mutLBSgene (Approved drugs only) |
Drug status | DrugBank ID | Name | Type | Drug structure |
Experimental | DB04069 | 5,6-Dihydro-Benzo[H]Cinnolin-3-Ylamine | Small molecule | |
Experimental | DB04395 | Phosphoaminophosphonic Acid-Adenylate Ester | Small molecule | |
Experimental | DB07444 | 6-(3-AMINOPROPYL)-4,9-DIMETHYLPYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE | Small molecule |
Gene-centered ligand-gene interaction network |
Ligands binding to mutated ligand binding site of DAPK1 go to BioLip |
Ligand ID | Ligand short name | Ligand long name | PDB ID | PDB name | mutLBS | ANP | AMP-PNP | 1ig1 | A | A40 K42 V96 | ANP | AMP-PNP | 1jkk | A | A40 K42 V96 | ANP | AMP-PNP | 1jkl | A | A40 K42 V96 | DRG | 5,6-DIHYDRO-BENZO[H]CINNOLIN-3-YLAMINE | 1p4f | A | A40 K42 V96 | STU | STAUROSPORINE | 1wvy | A | A40 K42 V96 | ADP | ADP | 2w4j | A | A40 K42 V96 | ADP | ADP | 2w4k | A | A40 K42 V96 | ADP | ADP | 2xuu | A | A40 K42 V96 | OSV | RUTHENIUM OCTASPORINE 4 | 2yak | A | A40 K42 V96 | ANP | AMP-PNP | 3dfc | B | A40 K42 V96 | ADP | ADP | 3eh9 | A | A40 K42 V96 | ANP | AMP-PNP | 3eha | A | A40 K42 V96 | ADP | ADP | 3f5g | A | A40 K42 V96 | ANP | AMP-PNP | 3f5u | A | A40 K42 V96 | ANP | AMP-PNP | 3gu4 | A | A40 K42 V96 | ANP | AMP-PNP | 3gu5 | A | A40 K42 V96 | ADP | ADP | 3gu6 | A | A40 K42 V96 | ADP | ADP | 3gu7 | A | A40 K42 V96 | 3GU | N6-CYCLOPENTYLADENOSINE | 3gu8 | A | A40 K42 V96 | GUB | 9-ALPHA-L-LYXOFURANOSYL-N-(2-PHENYLETHYL)-9H-PURIN-6-AMINE | 3gub | A | A40 K42 V96 | ACP | ADENOSINE 5'-[BETA,GAMMA-METHYLENE]TRIPHOSPHATE | 3zxt | A | A40 K42 V96 | ACP | ADENOSINE 5'-[BETA,GAMMA-METHYLENE]TRIPHOSPHATE | 3zxt | B | A40 K42 V96 | ACP | ADENOSINE 5'-[BETA,GAMMA-METHYLENE]TRIPHOSPHATE | 3zxt | C | A40 K42 V96 | ACP | ADENOSINE 5'-[BETA,GAMMA-METHYLENE]TRIPHOSPHATE | 3zxt | D | A40 K42 V96 | 38G | 4-(3-{3-[(R)-{[2-(DIMETHYLAMINO)ETHYL]AMINO}(HYDROXY) METHYL]PHENYL}IMIDAZO[1,2-B]PYRIDAZIN-6-YL)-2- METHOXYPHENOL | 4txc | A | A40 K42 V96 | 2AN | 8-ANILINO-1-NAPHTHALENE SULFONATE | 5aut | A | A40 K42 V96 | LU2 | LUTEOLIN | 5auu | A | A40 K42 V96 | AGI | APIGENIN | 5auv | A | A40 K42 V96 | QUE | QUERCETIN | 5auw | A | A40 K42 V96 | KMP | KAEMPFEROL | 5aux | A | A40 K42 V96 | MRI | MORIN | 2-[2,4-BIS(OXIDANYL)PHENYL]-3,5,7-TRIS(OXIDANYL) CHROMEN-4-ONE | 5auy | A | A40 K42 V96 | GEN | GENISTEIN | 5auz | A | A40 K42 V96 | KMP | KAEMPFEROL | 5av2 | A | A40 K42 V96 | KMP | KAEMPFEROL | 5av3 | A | A40 K42 V96 | GEN | GENISTEIN | 5av4 | A | A40 K42 V96 | BD4 | 6-(3-AMINOPROPYL)-4,9-DIMETHYLPYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE | 1wvx | A | A40 V96 | 4FT | PHTHALAZINE | 4yo4 | A | A40 V96 | DKG | 4-METHYLPYRIDAZINE | 4ypd | A | A40 V96 | 47X | 3',4',7-TRIHYDROXYISOFLAVONE | 5av0 | A | A40 V96 | IOD | IODIDE | 5av3 | A | F183 | IOD | IODIDE | 5av3 | A | F183 | BR | BROMIDE | 5av1 | A | G16 K29 | BR | BROMIDE | 5av2 | A | G16 K29 | BR | BROMIDE | 5av4 | A | G16 K29 | MG | MAGNESIUM(2+) | 4pf4 | A | K42 | MG | MAGNESIUM(2+) | 4tl0 | A | K42 | CL | CHLORIDE | 5auv | A | K42 | CL | CHLORIDE | 5aux | A | K42 | BR | BROMIDE | 5av1 | A | K42 | BR | BROMIDE | 5av2 | A | K42 | IOD | IODIDE | 5av3 | A | K42 | IOD | IODIDE | 5av3 | A | K42 | BR | BROMIDE | 5av4 | A | K42 | BR | BROMIDE | 5av1 | A | P181 | IOD | IODIDE | 5av3 | A | P181 |
Top |
Conservation information for LBS of DAPK1 |
Multiple alignments for P53355 in multiple species |
LBS | AA sequence | # species | Species | A25 | GSGQFAVVKKC | 2 | Homo sapiens, Mus musculus | A25 | GSGQFAVVRRV | 1 | Caenorhabditis elegans | A40 | TGLQYAAKFIK | 2 | Homo sapiens, Mus musculus | A40 | TGEKYAAKFIK | 1 | Caenorhabditis elegans | A97 | ILELVAGGELF | 2 | Homo sapiens, Mus musculus | A97 | VLELVSGGELF | 1 | Caenorhabditis elegans | D139 | QIAHFDLKPEN | 2 | Homo sapiens, Mus musculus | D139 | HIVHLDIKPEN | 1 | Caenorhabditis elegans | D161 | RIKIIDFGLAH | 2 | Homo sapiens, Mus musculus | D161 | QIKIIDFGLSR | 1 | Caenorhabditis elegans | E100 | LVAGGELFDFL | 2 | Homo sapiens, Mus musculus | E100 | LVSGGELFDHV | 1 | Caenorhabditis elegans | E143 | FDLKPENIMLL | 2 | Homo sapiens, Mus musculus | E143 | LDIKPENVMLK | 1 | Caenorhabditis elegans | E17 | YYDTGEELGSG | 2 | Homo sapiens, Mus musculus | E17 | VYEIETELGSG | 1 | Caenorhabditis elegans | E64 | EDIEREVSILK | 2 | Homo sapiens, Mus musculus | E64 | QNIEREVRVLQ | 1 | Caenorhabditis elegans | E94 | VILILELVAGG | 2 | Homo sapiens, Mus musculus | E94 | VIIVLELVSGG | 1 | Caenorhabditis elegans | F102 | AGGELFDFLAE | 2 | Homo sapiens, Mus musculus | F102 | SGGELFDHVCA | 1 | Caenorhabditis elegans | F162 | IKIIDFGLAHK | 2 | Homo sapiens, Mus musculus | F162 | IKIIDFGLSRE | 1 | Caenorhabditis elegans | F183 | FGTPEFVAPEI | 2 | Homo sapiens, Mus musculus | F183 | VGTPEFVAPEV | 1 | Caenorhabditis elegans | F24 | LGSGQFAVVKK | 2 | Homo sapiens, Mus musculus | F24 | LGSGQFAVVRR | 1 | Caenorhabditis elegans | G16 | DYYDTGEELGS | 2 | Homo sapiens, Mus musculus | G16 | DVYEIETELGS | 1 | Caenorhabditis elegans | G20 | TGEELGSGQFA | 2 | Homo sapiens, Mus musculus | G20 | IETELGSGQFA | 1 | Caenorhabditis elegans | G22 | EELGSGQFAVV | 2 | Homo sapiens, Mus musculus | G22 | TELGSGQFAVV | 1 | Caenorhabditis elegans | H131 | GVYYLHSLQIA | 2 | Homo sapiens, Mus musculus | H131 | AVRHLHSLHIV | 1 | Caenorhabditis elegans | I160 | PRIKIIDFGLA | 2 | Homo sapiens, Mus musculus | I160 | SQIKIIDFGLS | 1 | Caenorhabditis elegans | I209 | GVITYILLSGA | 2 | Homo sapiens, Mus musculus | I209 | GVVTYILLSGG | 1 | Caenorhabditis elegans | I266 | KKRMTIQDSLQ | 2 | Homo sapiens, Mus musculus | I266 | DQRATVEECLQ | 1 | Caenorhabditis elegans | I77 | -HPNVITLHEV | 2 | Homo sapiens, Mus musculus | I77 | GNSNVVELHAV | 1 | Caenorhabditis elegans | K141 | AHFDLKPENIM | 2 | Homo sapiens, Mus musculus | K141 | VHLDIKPENVM | 1 | Caenorhabditis elegans | K222 | FLGDTKQETLA | 2 | Homo sapiens, Mus musculus | K222 | FLGDNRDETFS | 1 | Caenorhabditis elegans | K29 | FAVVKKCREKS | 2 | Homo sapiens, Mus musculus | K29 | FAVVRRVRDRK | 1 | Caenorhabditis elegans | K42 | LQYAAKFIKKR | 2 | Homo sapiens, Mus musculus | K42 | EKYAAKFIKKR | 1 | Caenorhabditis elegans | L19 | DTGEELGSGQF | 2 | Homo sapiens, Mus musculus | L19 | EIETELGSGQF | 1 | Caenorhabditis elegans | L196 | YEPLGLEADMW | 2 | Homo sapiens, Mus musculus | L196 | YEALSPATDMW | 1 | Caenorhabditis elegans | L218 | GASPFLGDTKQ | 2 | Homo sapiens, Mus musculus | L218 | GGSPFLGDNRD | 1 | Caenorhabditis elegans | L68 | REVSILKEIQ- | 1 | Homo sapiens | L68 | REVRVLQKIRG | 1 | Caenorhabditis elegans | L68 | REVSILKEIR- | 1 | Mus musculus | L79 | PNVITLHEVYE | 2 | Homo sapiens, Mus musculus | L79 | SNVVELHAVYE | 1 | Caenorhabditis elegans | L91 | KTDVILILELV | 2 | Homo sapiens, Mus musculus | L91 | ASDVIIVLELV | 1 | Caenorhabditis elegans | L93 | DVILILELVAG | 2 | Homo sapiens, Mus musculus | L93 | DVIIVLELVSG | 1 | Caenorhabditis elegans | L95 | ILILELVAGGE | 2 | Homo sapiens, Mus musculus | L95 | IIVLELVSGGE | 1 | Caenorhabditis elegans | M146 | KPENIMLLDRN | 2 | Homo sapiens, Mus musculus | M146 | KPENVMLKQRG | 1 | Caenorhabditis elegans | M200 | GLEADMWSIGV | 2 | Homo sapiens, Mus musculus | M200 | SPATDMWAVGV | 1 | Caenorhabditis elegans | N144 | DLKPENIMLLD | 2 | Homo sapiens, Mus musculus | N144 | DIKPENVMLKQ | 1 | Caenorhabditis elegans | P142 | HFDLKPENIML | 2 | Homo sapiens, Mus musculus | P142 | HLDIKPENVML | 1 | Caenorhabditis elegans | P181 | NIFGTPEFVAP | 2 | Homo sapiens, Mus musculus | P181 | DMVGTPEFVAP | 1 | Caenorhabditis elegans | Q23 | ELGSGQFAVVK | 2 | Homo sapiens, Mus musculus | Q23 | ELGSGQFAVVR | 1 | Caenorhabditis elegans | Q267 | KRMTIQDSLQH | 2 | Homo sapiens, Mus musculus | Q267 | QRATVEECLQH | 1 | Caenorhabditis elegans | S132 | VYYLHSLQIAH | 2 | Homo sapiens, Mus musculus | S132 | VRHLHSLHIVH | 1 | Caenorhabditis elegans | S21 | GEELGSGQFAV | 2 | Homo sapiens, Mus musculus | S21 | ETELGSGQFAV | 1 | Caenorhabditis elegans | T225 | DTKQETLANVS | 2 | Homo sapiens, Mus musculus | T225 | DNRDETFSNIT | 1 | Caenorhabditis elegans | T265 | PKKRMTIQDSL | 2 | Homo sapiens, Mus musculus | T265 | VDQRATVEECL | 1 | Caenorhabditis elegans | T78 | HPNVITLHEVY | 2 | Homo sapiens, Mus musculus | T78 | NSNVVELHAVY | 1 | Caenorhabditis elegans | V26 | SGQFAVVKKCR | 2 | Homo sapiens, Mus musculus | V26 | SGQFAVVRRVR | 1 | Caenorhabditis elegans | V27 | GQFAVVKKCRE | 2 | Homo sapiens, Mus musculus | V27 | GQFAVVRRVRD | 1 | Caenorhabditis elegans | V96 | LILELVAGGEL | 2 | Homo sapiens, Mus musculus | V96 | IVLELVSGGEL | 1 | Caenorhabditis elegans | Y128 | ILNGVYYLHSL | 1 | Homo sapiens | Y128 | ILLAVRHLHSL | 1 | Caenorhabditis elegans | Y128 | ILSGVYYLHSL | 1 | Mus musculus |
Copyright © 2016-Present - The University of Texas Health Science Center at Houston |